Gamble Jones Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-6,566
| Closed | -$302K | – | 207 |
|
2016
Q3 | $302K | Buy |
6,566
+3
| +0% | +$138 | 0.03% | 181 |
|
2016
Q2 | $330K | Buy |
6,563
+2
| +0% | +$101 | 0.04% | 181 |
|
2016
Q1 | $351K | Sell |
6,561
-122
| -2% | -$6.53K | 0.04% | 174 |
|
2015
Q4 | $439K | Sell |
6,683
-1,893
| -22% | -$124K | 0.05% | 169 |
|
2015
Q3 | $484K | Sell |
8,576
-123
| -1% | -$6.94K | 0.06% | 166 |
|
2015
Q2 | $514K | Sell |
8,699
-73
| -0.8% | -$4.31K | 0.05% | 171 |
|
2015
Q1 | $547K | Sell |
8,772
-298
| -3% | -$18.6K | 0.06% | 161 |
|
2014
Q4 | $522K | Sell |
9,070
-498
| -5% | -$28.7K | 0.05% | 166 |
|
2014
Q3 | $514K | Buy |
9,568
+3
| +0% | +$161 | 0.06% | 163 |
|
2014
Q2 | $501K | Sell |
9,565
-481
| -5% | -$25.2K | 0.06% | 168 |
|
2014
Q1 | $531K | Sell |
10,046
-797
| -7% | -$42.1K | 0.06% | 157 |
|
2013
Q4 | $435K | Sell |
10,843
-2,722
| -20% | -$109K | 0.05% | 167 |
|
2013
Q3 | $512K | Sell |
13,565
-2,397
| -15% | -$90.5K | 0.07% | 156 |
|
2013
Q2 | $626K | Buy |
+15,962
| New | +$626K | 0.08% | 142 |
|